News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific
Arndt Vogel/X
Apr 25, 2025, 12:50

Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific

Arndt Vogel, Managing Senior Consultant and a Professor in the Department of Gastroenterology at Hannover Medical School, shared an article by Choong-kun Lee, et al. on X:

“RW Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific.

  • 1,141 pts, 55.1% 2nd line.
  • mPFS 2.9; mOS: 8 mo.
  • Lenva better compared to Sora, TKI plus ICI promising.
  • IMbrave 251 phase-3 awaited!

Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific

Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries.

Authors: Choong-kun Lee, et al.

Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific

Arndt Vogel Asia Pacific atezolizumab Bevacizumab cancer Choong-kun Lee fight against cancer Global fight against cancer Hannover Medical School HCC liver cancer OncoDaily Oncology
Special Coverage
Science
Apr 25, 2025, 12:50
Arndt Vogel: First-Line Atezolizumab plus Bevacizumab for HCC in Asia-Pacific
Blog
Apr 25, 2025, 12:42
Peter WT Pisters: A Conversation with a Living Legend honoring Ken Burns
Blog
Apr 25, 2025, 12:33
Paolo Tarantino: Two practice-changing ADC phase 3 trials announced to be positive
Blog
Apr 25, 2025, 12:19
Yan Leyfman: Breakthrough in Engineered Tissue Production
Blog
Apr 25, 2025, 11:31
Norman Ng: How should healthcare in Hong Kong develop?
Blog
Apr 25, 2025, 11:15
Amol Akhade: Data to look forward at AACR2025
Blog
Apr 25, 2025, 11:05
MD Anderson researchers are set to present breakthrough findings at the 2025 AACR Annual Meeting
Science
Apr 25, 2025, 10:57
Triparna Sen: Lipid Metabolism Remodeling and Ferroptosis Priming in Lung Adenocarcinoma
Blog
Apr 25, 2025, 10:42
True leadership is about bringing people and organizations together to create lasting change - American Cancer Society
Blog
Apr 25, 2025, 10:32
ASCO received the Dorothy Schachne Partners in Progress Award at CancerCare
Blog
Apr 25, 2025, 09:57
What to Expect at the AACR Annual Meeting 2025: Key Highlights and Must-Attend Sessions​
Blog
Apr 25, 2025, 09:24
Shankar Siva Supports Andrea Bezjak as Candidate for IASLC Presidency